Penas-Prado M, Wu J, Cahill DP et al (2020) Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) oligodendroglioma workshop. Neurooncol Adv 2:vdz048

PubMed  Google Scholar 

Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol 20:iv1–iv86

Article  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820

Article  PubMed  Google Scholar 

Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weller M, van den Bent M, Preusser M et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18:170–186

Article  PubMed  Google Scholar 

Ostrom QT, Price M, Neff C et al (2023) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016–2020. Neuro Oncol 25:iv1–iv99

Article  PubMed  PubMed Central  Google Scholar 

Figarella-Branger D, Mokhtari K, Dehais C et al (2014) Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations. Neuro Oncol 16:1244–1254

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dubbink HJ, Atmodimedjo PN, Kros JM et al (2016) Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro Oncol 18:388–400

Article  CAS  PubMed  Google Scholar 

Tabouret E, Nguyen AT, Dehais C et al (2016) Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort. Acta Neuropathol 132:625–634

Article  PubMed  Google Scholar 

Cimino PJ, Zager M, McFerrin L et al (2017) Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery. Acta Neuropathol Commun 5:39

Article  PubMed  PubMed Central  Google Scholar 

Figarella-Branger D, Mokhtari K, Dehais C et al (2016) Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas. Neuro Oncol 18:888–890

Article  PubMed  PubMed Central  Google Scholar 

Appay R, Dehais C, Maurage CA et al (2019) CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. Neuro Oncol 21:1519–1528

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park YW, Kim S, Han K et al (2024) Rethinking extent of resection of contrast-enhancing and non-enhancing tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification. Eur Radiol 34:1376–1387

Article  CAS  PubMed  Google Scholar 

Suzuki H, Aoki K, Chiba K et al (2015) Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458–468

Article  CAS  PubMed  Google Scholar 

Kamble AN, Agrawal NK, Koundal S et al (2023) Imaging-based stratification of adult gliomas prognosticates survival and correlates with the 2021 WHO classification. Neuroradiology 65:41–54

Article  PubMed  Google Scholar 

Park YW, Jang G, Kim SB et al (2024) Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recovery. Neuro Oncol 26:1921–1932

Azizova A, Prysiazhniuk Y, Wamelink I, Petr J, Barkhof F, Keil VC (2024) Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance. AJNR Am J Neuroradiol 45:1053–1062

Jiang Z, Le Bas JF, Grand S et al (2011) Prognostic value of perfusion MR imaging in patients with oligodendroglioma: a survival study. J Neuroradiol 38:53–61

Article  CAS  PubMed  Google Scholar 

Zetterling M, Berhane L, Alafuzoff I, Jakola AS, Smits A (2017) Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases. PLoS One 12:e0188419

Article  PubMed  PubMed Central  Google Scholar 

Suchorska B, Schüller U, Biczok A et al (2019) Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning. Eur J Cancer 107:15–27

Article  CAS  PubMed  Google Scholar 

Lee JO, Ahn SS, Choi KS et al (2024) Added prognostic value of 3D deep learning-derived features from preoperative MRI for adult-type diffuse gliomas. Neuro Oncol 26:571–580

Article  CAS  PubMed  Google Scholar 

Fortin D, Cairncross GJ, Hammond RR (1999) Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment. Neurosurgery 45:1279–1291

Article  CAS  PubMed  Google Scholar 

Reiche W, Grunwald I, Hermann K, Deinzer M, Reith W (2002) Oligodendrogliomas. Acta Radiol 43:474–482

CAS  PubMed  Google Scholar 

White ML, Zhang Y, Kirby P, Ryken TC (2005) Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? AJNR Am J Neuroradiol 26:784–790

PubMed  PubMed Central  Google Scholar 

Zhu Q, Jiang H, Cui Y et al (2024) Intratumoral calcification: not only a diagnostic but also a prognostic indicator in oligodendrogliomas. Eur Radiol 34:3674–3685

Article  CAS  PubMed  Google Scholar 

Giannini C (2001) Oligodendrogliomas—reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 60:248–262

Article  CAS  PubMed  Google Scholar 

Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972

Article  PubMed  Google Scholar 

Karschnia P, Vogelbaum MA, van den Bent M et al (2021) Evidence-based recommendations on categories for extent of resection in diffuse glioma. Eur J Cancer 149:23–33

Article  PubMed  Google Scholar 

Go JL, Zee CS (1998) Unique CT imaging advantages. Hemorrhage and calcification. Neuroimaging Clin N Am 8:541–558

CAS  PubMed  Google Scholar 

Shin I, Sim Y, Choi SH et al (2024) Revisiting prognostic factors of gliomatosis cerebri in adult-type diffuse gliomas. J Neurooncol 168:239–247

Article  CAS  PubMed  Google Scholar 

Park YW, Eom J, Kim D et al (2022) A fully automatic multiparametric radiomics model for differentiation of adult pilocytic astrocytomas from high-grade gliomas. Eur Radiol 32:4500–4509

Article  CAS  PubMed  Google Scholar 

Heagerty PJ, Zheng YY (2005) Survival model predictive accuracy and ROC curves. Biometrics 61:92–105

Article  PubMed  Google Scholar 

Akaike H (1981) Citation Classic—a new look at the statistical-model identification. CC/Eng Technol Appl Sci 51:22-22

Sasaki H, Kitamura Y, Toda M, Hirose Y, Yoshida K (2024) Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain Tumor Pathol 41:43–49

Hervey-Jumper SL, Zhang Y, Phillips JJ et al (2023) Interactive effects of molecular, therapeutic, and patient factors on outcome of diffuse low-grade glioma. J Clin Oncol 41:2029–2042

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harrell FE Jr, Lee KL, Califf RM, Pryor DB, Rosati RA (1984) Regression modelling strategies for improved prognostic prediction. Stat Med 3:143–152

Article